[1] BOULTON AJ. The diabetic foot:a global view.Diabetes Metab Res Rev. 2000;16(Suppl 1): S2-5.
[2] International Diabetes Federation. IDF DIABETES ATLAS, 9th edition 2019.
[3] SINGH N, ARMSTRONG DG, LISPSKY BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217-228.
[4] 中华医学会糖尿病学分会, 中华医学会感染病学分会, 中华医学会组织修复与再生分会.中国糖尿病足防治指南(2019版)(Ⅰ)[J].中华糖尿病杂志,2019,11(2):92-108.
[5] MARGOLIS DJ, MALAY DS, HOFFSTAD OJ, et al. Incidence of diabetic foot ulcer and lower extremity amputation among Medicare beneficiaries, 2006 to 2008: Data Points #2. Rockville (MD):Agency for Healthcare Research and Quality(US), 2011.
[6] CATTERALL RC, MARTIN MM, OAKLEY W. Aetiology and management of lesions of the feet in diabetesp. Br Med J. 1956;2:953-957.
[7] CHEN C. CiteSpaceⅡ: Detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Tech. 2006; 57(3):359-377.
[8] DENG W, BOEY J, CHEN B,et al. Platelet-rich plasma, bilayered acellular matrix grafting and negative pressure wound therapy in diabetic foot infection.J Wound Care. 2016;25(7):393-397.
[9] CHEN Y, MA Y, LI N, et al. Efficacy and long-term longitudinal follow-up of bone marrow mesenchymal cell transplantation therapy in a diabetic patient with recurrent lower limb bullosisdiabeticorum.Stem Cell Res Ther. 2018;9(1):99.
[10] ZHAO J, DENG W, ZHANG Y, et al. Association between Serum Cystatin C and Diabetic Foot Ulceration in Patients with Type 2 Diabetes: A Cross-Sectional Study. J Diabetes Res. 2016;2016:8029340.
[11] LIPSKY BA, BERENDT AR, CORNIA PB,et al.2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections. Clin Infect Dis. 2012; 54(12):e132-173.
[12] PARENTEAU-BAREIL R , GAUVIN R , BERTHOD F. Collagen-Based Biomaterials for Tissue Engineering Applications.Materials. 2010;3(3): 1863-1887.
[13] KUMAR PT, LAKSHMANAN VK, ANILKUMAR TV, et al. Flexible and microporous chitosan hydrogel/nanoZnO composite bandages for wound dressing: in vitro and in vivo evaluation. ACS Appl Mater Interfaces. 2012;4(5):2618-2629.
[14] LAHIRI BB, BAGAVATHIAPPAN S, JAYAKUMAR T, et al. Medical applications of infrared thermography: A review.Infrared Phys Technol. 2012;55(4):221-235.
[15] MILLS JL, CONTE MS, ARMSTRONG DG, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI).J Vascular Surg. 2014;59(1):220-234.
[16] 中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018, 38(4):292-344.
[17] MIYAJIMA S, SHIRAI A, YAMAMOTO S, et al. Risk factors for major limb amputations in diabetic foot gangrene patients.Diabetes Res Clin Pract. 2006;71(3):272-279.
[18] MARMOLEJO VS, ARNOLD JF, PONTICELLO M, et al. Charcot foot:clinical clues, diagnostic strategies,and treatment principles.Am Fam Physician. 2018;97(9):594-599.
[19] MORBACH S, FURCHERT H, GROBLINGHOFF U, et al. Long-term prognosis of diabetic foot patients and their limbs:amputation and death over the course of a decade. Diabetes Care. 2012;35(10): 2021-2027.
[20] GURJALA AN, GERINGER MR, SETH AK, et al. Development of a novel,highly quantitative in vivo model for the study of biofilm-impaired cutaneous wound healing. Wound Repair Regen. 2011;19(3):400-410.
[21] HURLOW J, BOWLER PG. Potential implications of biofilm in chronic wounds:a case series. J Wound Care. 2012;21(3):109-110.
[22] WOLCOTT RD, COX S. More effective cell-based therapy through biofilm suppression. J Wound Care. 2013;22(1):26-31.
[23] HEYBOER M. Hyperbaric oxygen therapy side effects-where do we stand? J Am Coll Clin Wound Spec. 2016;8(1-3):2-3.
[24] 徐进,殷嫦嫦,宋伟,等.间充质干细胞治疗糖尿病足溃疡的Meta分析[J].中国糖尿病杂志,2019,27(6):417-423.
[25] ALBEHAIRY A, ABDELGHAFFAR H, ABDELHAFEZ H, et al. Autologous mesenchymal stem cells in treatment of recalcitrant neuropathic diabetic foot ulcer: randomised controlled trial. Diabetologia. 2016; 59(1):S19.
[26] GONZALES KAU, FUCHS E. Skin and Its Regenerative Powers:An Alliance between Stem Cells and Their Niche.Dev Cell. 2017;43(4):387-401.
[27] YANG Z, HE C, HE J, et al. Curcumin-mediated bone marrow mesenchymal stem cell sheets create a favorable immune microenvironment for adult full-thickness cutaneous wound healing.Stem Cell Res Ther. 2018;9(1):21.
[28] SHINGYOCHI Y, ORBAY H, MIZUNO H. Adipose-derived stem cells for wound repair and regeneration.Expert Opin Biol Ther. 2015; 15(9):1285-1292.
[29] WU YY, JIAO YP, XIAO LL, et al. Experimental Study on Effects of Adipose-Derived Stem Cell-Seeded Silk Fibroin Chitosan Film on Wound Healing of a Diabetic Rat Model.Ann Plast Surg. 2018;80(5):572-580.
[30] 刘瑾,袁晓勇,袁戈恒,等. 糖尿病患者高危足筛查及分级、干预规范流程的构建[J]. 中华糖尿病杂志,2017,9(5):281-285.
[31] AHMAD A, ABUJBARA M, JADDOU H, et al. Anxiety and depression among adult patients with diabetic foot: prevalence and associated factors. J Clin Med Res. 2018;10(5):411-418.
[32] UDOVICHENKO OV, MAXIMOVA NV, AMOSOVA MV, et al.Prevalence and prognostic value of depression and anxiety in patients with diabetic foot ulcers and possibilities of their treatment. Curr Diabetes Rev. 2017; 13(1):97-106.
[33] IVERSEN MM, TELL GS, ESPEHAUG B, et al. Is depression a risk factor for diabetic foot ulcers? 11-years follow-up of the Nord-Trøndelag Health Study (HUNT). J Diabetes Complications. 2015;29(1):20-25.
[34] O’NEILL SM, KABIR Z, MCNAMARA G, et al. Comorbid depression and risk of lower extremity amputation in people with diabetes:systematic review and meta-analysis. BMJ Open Diabetes Res Care. 2017;5(1): e000366.
[35] MONAMI M, LONGO R, DESIDERI CM, et al. The diabetic person beyond a foot ulcer: healing, recurrence, and depressive symptoms. J Am Podiatr Med Assoc. 2008;98(2):130-136.
[36] FEINGOLD D, BRILL S, GOOR-ARYEH I, et al. The association between severity of depression and prescription opioid misuse among chronic pain patients with and without anxiety: a Cross-sectional study. J Affect Disord. 2018;235:293-302.
|